Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma

Journal of Gastrointestinal Surgery

Volumn 11, Issue 12, 2007, Pages 1636-1646

  Sonnenday, Christopher J ^a,c   Dimick, Justin B ^a   Schulick, Richard D ^b   Choti, Michael A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Geographic disparity; Hepatocellular cancer; Liver transplantation; Racial disparity; Surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CATHETER ABLATION; CLINICAL PRACTICE; ETHNOLOGY; FEMALE; HEALTH CARE DELIVERY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RESIDENTIAL CARE; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CATCHMENT AREA (HEALTH); CATHETER ABLATION; FEMALE; HEALTHCARE DISPARITIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 36148943561     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0315-8     Document Type: Article

References (41)

1. Bosch FX, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 supp 1):S5-16.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340(10):745-750.
3. Ries LAG, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Insititute; 2007.
4. El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5(1):87-107. vi.
5. Davila JA, et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127(5):1372-1380.
6. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40(3):225-235.
7. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25(2):181-200.
8. Cha CH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238(3):315-321. discussion 321-323.
9. Shiina S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129(1):122-130.
10. Lin SM, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology. 2004;127(6):1714-1723.
11. Livraghi T, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210(3):655-661.
12. Marrero JA, Pelletier S. Hepatocellular carcinoma. Clin Liver Dis. 2006;10(2):339-51. ix.
13. Hemming AW, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233(5):652-659.
14. Mazzaferro V, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-699.
15. National Center for Health Statistics (US). Atlas of United States Mortality NCHS Atlas CD-ROM No.1. Hyattsville, MD: Dept. of Health and Human Services; 1997.
16. Makuc DM, et al. Health service areas for the United States. Vital Health Stat. 1991;2(112):1-102.
17. Makuc DM, et al. The use of health service areas for measuring provider availability. J Rural Health. 1991;7(4 supp):347-356.
18. Cha C, et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003;197(5):753-758.
19. Fong Y, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229(6):790-799. discussion 799-800.
20. Yao FY, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002;8(9):765-774.
21. Yao FY, Roberts JP. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time? Liver Transpl. 2004;10(7):919-921.
22. Yao FY, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11(12):1505-1514.
23. Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006;98(12):1934-1939.
24. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006;4(1):104-110. quiz 4-5.
25. El-Serag HB, et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006;44(1):158-166.
26. Morris AM, et al. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg. 2006;203(6):787-794.
27. Dominitz JA, et al. Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia. Med Care. 2002;40(1 supp):I14-I26.
28. Eloubeidi MA, et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg. 2006;192(3):322-329.
29. Smedley BD, et al. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, vol xvi. Washington, DC: National Academies; 2003. p. 764.
30. Dartmouth Medical School. Center for the Evaluative Clinical Sciences. The Dartmouth Atlas of Health Care 1998, 1 Atlas. Chicago, IL: American Hospital; 1998. 305 pp.
31. Skinner J, et al. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med. 2003;349(14):1350-1359.
32. Weinstein JN, et al. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine. 2006;31(23):2707-2714.
33. Pope GD, Birkmeyer JD, Finlayson SR. National trends in utilization and in-hospital outcomes of bariatric surgery. J Gastrointest Surg. 2002;6(6):855-860. discussion 861.
34. Dimick JB, Finlayson SR, Birkmeyer JD. Regional availability of high-volume hospitals for major surgery. Health Aff (Millwood) 2004;Suppl Web Exclusives:VAR45-VAR53.
35. Finlayson SR, et al. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37(2):204-209.
36. Baicker K, Chandra A, Skinner JS. Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med. 2005;48(1 supp):S42-53.
37. Reid AE, et al. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl. 2004;10(7):834-841.
38. Powe NR, Boulware LE. The uneven distribution of kidney transplants: getting at the root causes and improving care. Am J Kidney Dis. 2002;40(4):861-863.
39. Pomfret EA, et al. Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant. 2007;7(supp 1):1376-1389.
40. Bruix J, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology. 1998;27(6):1578-1583.
41. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429-442.